ArticleOncotarget2018

Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits.

Takashi Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.